Roxana Mehran, MD, is an internationally renowned interventional cardiologist, clinical research expert and trialist in the field of cardiovascular disease. She is amongst the most prolific researchers in the United States and is a globally-respected leader of an academic research center focused on designing and implementing randomized clinical trials, outcomes research projects, and high impact academic publications. She has served as principal investigator for numerous global studies, developed important practice guidelines for treating patients with cardiovascular disease. She has focused on personalized medicine and developed individual risk scores for bleeding and acute kidney injury, participates regularly in developing clinical guidelines, and has authored over 1,800 peer-reviewed articles. Dr. Mehran currently serves as member and 2025-2026 Vice President on the Board of Trustees of The American College of Cardiology (ACC). She is a founder and Chief Scientific Officer of the Cardiovascular Research Foundation (CRF). She ranked 36th in the “Best Female Scientists in the World” and has been included for the past eight consecutive years in Clarivate Analytics: “Most Cited Researchers – Top 1%” as well as “The World’s Most Influential Scientific Minds”.

Kerry has been the cardiac valve nurse specialist for the past 10 years in one of the busiest and largest structural centres in UK. She is responsible for managing the daily activities of the structural heart service from referral to treatment of patients with heart valve disease and ensures that efficient clinical care pathways are delivered. Her role is vital in maintaining strong collaboration and effective communication within the multidisciplinary team which are keys to ensuring a streamlined patient journey. She has been an instrument in successful development and implementation of innovative practices to address the different challenges in managing their structural heart patients. These processes included the single point of referral for all aortic valve disease patients within the region, same-day discharge post-TAVI procedure, virtual wards for structural heart patients, nurse-led clinics. These practices have enabled the centre to grow and perform 500-600 TAVI cases annually. She actively engages in sharing best practices through education both nationally and internationally. She is also passionate about promoting patients’ voices for the improvement of heart valve care.